AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
15,385,873
Share change
-348,779
Total reported value
$101,850,000
Price per share
$6.62
Number of holders
33
Value change
-$5,416,385
Number of buys
20
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q2 2016

As of 30 Jun 2016, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,385,873 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Boxer Capital, LLC, NEXTHERA CAPITAL LP, BlackRock Advisors LLC, Opaleye Management Inc., BlackRock Fund Advisors, and BlackRock Group LTD. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.